andrew_witty (ceo)

literal strings: andrew witty, Andrew Witty

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• andrew_witty is a CEO     
• andrew_witty is american     
• andrew_witty is the CEO of glaxosmithkline (biotechcompany)     
• andrew_witty is a person who belongs to the organization glaxosmithkline (biotechcompany)     
• glaxosmithkline terminated the employment of andrew_witty (ceo)     
• andrew_witty is a top member of glaxosmithkline (biotechcompany)     

categories

• person(100.0%)
• MBL @1116 (93.8%) on 12-sep-2018 [ Promotion of ceo:andrew_witty topmemberoforganization biotechcompany:glaxosmithkline ] using concept:ceo:andrew_witty
• ceo(100.0%)
• MBL @1116 (96.9%) on 12-sep-2018 [ Promotion of ceo:andrew_witty ceoof biotechcompany:glaxosmithkline ] using concept:ceo:andrew_witty
• OE @1018 (100.0%) on 01-oct-2016 [ http://www.cnbc.com/2016/09/19/gsk-ceo-andrew-witty-says-drugmakers-need-to-be-empathetic-and-not-try-to-defend-price-hikes.html https://www.theguardian.com/business/2016/mar/17/gsk-chief-andrew-witty-to-leave-drugmaker-pay-package http://www.bbc.com/news/business-35829278 http://www.bbc.co.uk/news/business-35829278 http://www.foxbusiness.com/features/2016/06/09/exclusive-glaxosmithkline-eyes-drugs-for-zika.html http://topics.wsj.com/person/W/andrew-witty/23 http://topics.wsj.com/person/W/andrew-witty/23 http://topics.wsj.com/person/W/andrew-witty/23 http://www.telegraph.co.uk/business/2016/03/17/glaxosmithkline-boss-sir-andrew-witty-to-step-down-in-2017/ http://topics.wsj.com/person/W/andrew-witty/23 http://www.wsj.com/articles/glaxosmithkline-says-andrew-witty-to-retire-as-ceo-1458199536 http://topics.wsj.com/person/W/andrew-witty/23 http://www.thisismoney.co.uk/money/markets/article-3416190/GlaxoSmithKline-begins-search-new-ceo-succeed-embattled-Sir-Andrew-Witty-investors-call-drugs-giant-split-up.html https://www.theguardian.com/business/2016/mar/17/gsk-chief-andrew-witty-to-leave-drugmaker-pay-package http://www.bloomberg.com/news/articles/2016-03-17/glaxo-chief-executive-witty-plans-to-step-down-next-year http://www.foxbusiness.com/features/2016/06/09/exclusive-glaxosmithkline-eyes-drugs-for-zika.html http://www.cnbc.com/2016/09/19/gsk-ceo-andrew-witty-says-drugmakers-need-to-be-empathetic-and-not-try-to-defend-price-hikes.html https://en.wikipedia.org/wiki/Andrew_Witty http://www.fiercebiotech.com/special-report/sir-andrew-witty-25-most-influential-people-biopharma-today http://www.fiercebiotech.com/special-report/sir-andrew-witty-25-most-influential-people-biopharma-today  ] using andrew_witty
• MBL @1040 (93.8%) on 14-feb-2017 [ Promotion of ceo:andrew_witty ceoof bank:glaxosmithkline ]
• SEAL @180 (99.8%) on 16-dec-2010 [ 1 2 3 4 5 6 7 8 9 ] using andrew_witty
• personnorthamerica(98.3%)
• SEAL @817 (64.9%) on 23-feb-2014 [ 1 ] using andrew_witty
• personus(96.5%)
• SEAL @820 (96.5%) on 05-mar-2014 [ 1 2 ] using andrew_witty

NELL has only weak evidence for items listed in grey

• professor
• SEAL @815 (51.1%) on 19-feb-2014 [ 1 2 3 4 ] using andrew_witty

relations

• agentbelongstoorganization
• glaxosmithkline (biotechcompany) (100.0%)
• CPL @1099 (93.8%) on 23-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:relatedto,concept:agenthierarchicallybelowagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentinteractswithagent" "Y~_X0~concept:proxyfor" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentcollaborateswithagent" ] using (andrew_witty, glaxosmithkline)
• OE @985 (89.2%) on 17-mar-2016 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• agentcollaborateswithagent
• glaxosmithkline (biotechcompany) (100.0%)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
• glaxosmithkline (biotechcompany) (100.0%)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
• gsk (biotechcompany) (98.4%)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (gsk, andrew_witty)
• gsk (biotechcompany) (98.4%)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (gsk, andrew_witty)
• agentcontrols
• glaxosmithkline (biotechcompany) (100.0%)
• SEAL @359 (99.6%) on 23-jul-2011 [ 1 2 3 4 5 6 7 8 ] using (andrew_witty, glaxosmithkline)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (andrew_witty, glaxosmithkline)
• ceoof
• glaxosmithkline (biotechcompany) (96.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• controlledbyagent
• glaxosmithkline (biotechcompany) (100.0%)
• OE @826 (99.0%) on 28-mar-2014 [   ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcollaborateswithagent" "Y~_X0~concept:agentcollaborateswithagent" "Y~X0~concept:agentinteractswithagent" "Y~_X0~concept:agentinteractswithagent" "Y~X0~concept:controlledbyagent" ] using (glaxosmithkline, andrew_witty)
• SEAL @331 (99.8%) on 03-jul-2011 [ 1 2 3 4 5 6 7 8 9 ] using (glaxosmithkline, andrew_witty)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
• mutualproxyfor
• glaxosmithkline (biotechcompany) (100.0%)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (biotechcompany) (100.0%)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• personbelongstoorganization
• glaxosmithkline (biotechcompany) (100.0%)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @965 (100.0%) on 17-dec-2015 [ http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:mutualproxyfor" "Y~_X0~concept:proxyfor" ] using (andrew_witty, glaxosmithkline)
• personleadsorganization
• glaxosmithkline (biotechcompany) (100.0%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (andrew_witty, glaxosmithkline)
• SEAL @190 (99.2%) on 16-jan-2011 [ 1 2 3 4 5 6 7 ] using (andrew_witty, glaxosmithkline)
• OE @886 (100.0%) on 12-nov-2014 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.youtube.com/watch?v=-K1SdY8vpwo http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.forbes.com/sites/matthewherper/2013/10/29/can-this-man-make-you-believe-in-drug-companies/ http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html  ] using (andrew_witty, glaxosmithkline)
• personterminatedbyorganization
• glaxosmithkline (biotechcompany) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationleadbyagent,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:organizationhastopmember,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:subpartof,concept:organizationhasperson" "Y~X0~concept:proxyof,concept:subpartof,concept:worker" ] using (glaxosmithkline, andrew_witty)
• proxyfor
• glaxosmithkline (biotechcompany) (98.4%)
• CPL @1103 (87.5%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• SEAL @551 (87.5%) on 10-apr-2012 [ 1 2 3 ] using (andrew_witty, glaxosmithkline)
• topmemberoforganization
• glaxosmithkline (biotechcompany) (93.8%)
• CPL @1096 (93.8%) on 18-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• worksfor
• glaxosmithkline (biotechcompany) (100.0%)
• SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @968 (86.1%) on 29-dec-2015 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)

NELL has only weak evidence for items listed in grey

• agentbelongstoorganization
• gsk (biotechcompany)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• agentcontrols
• gsk (biotechcompany)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg2 chief executive officer arg1" ] using (andrew_witty, gsk)
• ceoof
• gsk (biotechcompany)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 chief executive arg1" "arg2 chief arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• personbelongstoorganization
• gsk (biotechcompany)
• CPL @1099 (87.5%) on 23-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• personleadsorganization
• gsk (biotechcompany)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• proxyfor
• gsk (biotechcompany)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" ] using (andrew_witty, gsk)
• topmemberoforganization
• gsk (biotechcompany)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• worksfor
• gsk (biotechcompany)
• CPL @1098 (87.5%) on 21-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• agentbelongstoorganization
• glaxosmithkline (bank)
• CPL @1099 (93.8%) on 23-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:relatedto,concept:agenthierarchicallybelowagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentinteractswithagent" "Y~_X0~concept:proxyfor" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentcollaborateswithagent" ] using (andrew_witty, glaxosmithkline)
• OE @985 (89.2%) on 17-mar-2016 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1099 (93.8%) on 23-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:relatedto,concept:agenthierarchicallybelowagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentinteractswithagent" "Y~_X0~concept:proxyfor" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentcollaborateswithagent" ] using (andrew_witty, glaxosmithkline)
• OE @985 (89.2%) on 17-mar-2016 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• agentcollaborateswithagent
• glaxosmithkline (bank)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
• glaxosmithkline (ceo)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
• SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
• gsk (drug)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (gsk, andrew_witty)
• agentcontrols
• glaxosmithkline (bank)
• SEAL @359 (99.6%) on 23-jul-2011 [ 1 2 3 4 5 6 7 8 ] using (andrew_witty, glaxosmithkline)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• SEAL @359 (99.6%) on 23-jul-2011 [ 1 2 3 4 5 6 7 8 ] using (andrew_witty, glaxosmithkline)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg2 chief executive officer arg1" ] using (andrew_witty, gsk)
• ceoof
• glaxosmithkline (bank)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 chief executive arg1" "arg2 chief arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• mutualproxyfor
• glaxosmithkline (bank)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (glaxosmithkline, andrew_witty)
• SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (glaxosmithkline, andrew_witty)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
• OE @1039 (100.0%) on 02-feb-2017 [ http://www.philly.com/philly/blogs/phillypharma/GlaxoSmithKlines-Andrew-Witty-says-1-billion-price-tag-for-drug-development-is-a-myth.html  ] using (andrew_witty, glaxosmithkline)
• personbelongstoorganization
• glaxosmithkline (bank)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @965 (100.0%) on 17-dec-2015 [ http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:mutualproxyfor" "Y~_X0~concept:proxyfor" ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @965 (100.0%) on 17-dec-2015 [ http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:mutualproxyfor" "Y~_X0~concept:proxyfor" ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1099 (87.5%) on 23-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• personleadsorganization
• glaxosmithkline (bank)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (andrew_witty, glaxosmithkline)
• SEAL @190 (99.2%) on 16-jan-2011 [ 1 2 3 4 5 6 7 ] using (andrew_witty, glaxosmithkline)
• OE @886 (100.0%) on 12-nov-2014 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.youtube.com/watch?v=-K1SdY8vpwo http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.forbes.com/sites/matthewherper/2013/10/29/can-this-man-make-you-believe-in-drug-companies/ http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html  ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (andrew_witty, glaxosmithkline)
• SEAL @190 (99.2%) on 16-jan-2011 [ 1 2 3 4 5 6 7 ] using (andrew_witty, glaxosmithkline)
• OE @886 (100.0%) on 12-nov-2014 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.youtube.com/watch?v=-K1SdY8vpwo http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.forbes.com/sites/matthewherper/2013/10/29/can-this-man-make-you-believe-in-drug-companies/ http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html  ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• proxyfor
• glaxosmithkline (bank)
• CPL @1103 (87.5%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• SEAL @551 (87.5%) on 10-apr-2012 [ 1 2 3 ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1103 (87.5%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• SEAL @551 (87.5%) on 10-apr-2012 [ 1 2 3 ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" ] using (andrew_witty, gsk)
• topmemberoforganization
• glaxosmithkline (bank)
• CPL @1096 (93.8%) on 18-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• CPL @1096 (93.8%) on 18-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)
• worksfor
• glaxosmithkline (bank)
• SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @968 (86.1%) on 29-dec-2015 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• glaxosmithkline (ceo)
• SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (andrew_witty, glaxosmithkline)
• CPL @1103 (93.8%) on 06-mar-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
• OE @968 (86.1%) on 29-dec-2015 [ http://articles.economictimes.indiatimes.com/2013-11-18/news/44202459_1_gsk-india-pricing-all-india-organisation https://www.gov.uk/government/news/give-universities-bigger-role-in-growing-economy-witty http://www.huffingtonpost.co.uk/2013/12/02/glaxosmithkline-china-davidcameron_n_4370643.html http://www.businessweek.com/articles/2013-07-17/glaxosmithklines-andrew-witty-on-fixing-big-pharmas-bad-boy http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/sir-andrew-witty-25-most-influential-peop http://www.express.co.uk/finance/city/415561/Andrew-Witty-to-quit-key-role-at-GlaxoSmithKline  ] using (andrew_witty, glaxosmithkline)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
• gsk (drug)
• CPL @1098 (87.5%) on 21-jan-2018 [ "arg2 chief executive arg1" "arg2 chief executive officer arg1" "arg2 chief Sir arg1" ] using (andrew_witty, gsk)